MktsMarkets

Pulmonx Corporation
NASDAQ: LUNGKey statistics
LUNG News
Stories mentioning LUNG from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 20,586 | 22,598 | 21,502 | 23,859 | 22,538 | 23,765 | 20,387 | 20,783 |
| Cost of Goods Sold | 4,542 | 5,057 | 5,450 | 6,655 | 6,196 | 6,175 | 5,361 | 5,476 |
| Gross Profit | 16,044 | 17,541 | 16,052 | 17,204 | 16,342 | 17,590 | 15,026 | 15,307 |
| Operating Expenses | ||||||||
| Research & Development | 4,899 | 4,583 | 4,846 | 5,306 | 4,756 | 4,001 | 3,744 | 5,615 |
| Sales General & Admin | 24,101 | 22,861 | 25,599 | 26,702 | 26,149 | 27,006 | 25,411 | 25,314 |
| Total Operating Expenses | 29,000 | 27,444 | 30,445 | 32,008 | 30,905 | 31,007 | 29,155 | 30,929 |
| Operating Income (Loss) | (12,956) | (9,903) | (14,393) | (14,804) | (14,563) | (13,417) | (14,129) | (15,622) |
| Interest Income | 350.00 | 453.00 | 611.00 | 723.00 | 864.00 | 1,045 | 1,269 | 1,306 |
| Interest Expense | ||||||||
| Other Expense | 77.00 | (19.00) | 758.00 | (116.00) | 167.00 | 77.00 | (201.00) | (35.00) |
| Pretax Income | (13,505) | (10,239) | (13,829) | (14,996) | (14,313) | (13,137) | (13,952) | (15,242) |
| Tax Provision | 149.00 | 186.00 | 128.00 | 177.00 | 135.00 | 38.00 | 192.00 | 84.00 |
| Net Income (Loss) | (13,654) | (10,425) | (13,957) | (15,173) | (14,448) | (13,175) | (14,144) | (15,326) |
| Earnings Per Share (Basic) | (0.33) | (0.26) | (0.34) | (0.38) | (0.36) | (0.34) | (0.36) | (0.39) |
| Earnings Per Share (Diluted) | (0.33) | (0.26) | (0.34) | (0.38) | (0.36) | (0.34) | (0.36) | (0.39) |
| Weighted Average Shares Outstanding (Basic) | 41,898 | 40,686 | 40,937 | 40,430 | 39,955 | 39,111 | 39,276 | 38,943 |
| Weighted Average Shares Outstanding (Diluted) | 41,898 | 40,686 | 40,937 | 40,430 | 39,955 | 39,111 | 39,276 | 38,943 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About LUNG
Pulmonx Corporation (NASDAQ: LUNG) is a stock listed on the Nasdaq Stock Market under the ticker symbol LUNG. It last traded at $2.83 (Nov 4, 2026, 4:00 PM ET), up 4.0% on the day. That gives Pulmonx a market capitalisation of $121.5M.
Over the past 52 weeks LUNG has traded between $1.13 and $3.25.
Revenue for the quarter ended Mar 31, 2026 was $20.6M; a net loss of $13.7M. Revenue was down 8.7% from $22.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $20.6M | -$13.7M | -66.3% |
| Dec 31, 2025 | $22.6M | -$10.4M | -46.1% |
| Sep 30, 2025 | $21.5M | -$14.0M | -64.9% |
| Jun 30, 2025 | $23.9M | -$15.2M | -63.6% |
From Pulmonx’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…